BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31180485)

  • 1. Reduced Androgen Receptor Expression in Genital Skin Fibroblasts From Patients With 45,X/46,XY Mosaicism.
    Hornig NC; Demiri J; Rodens P; Murga Penas EM; Caliebe A; Eckstein AK; Schweikert HU; Audi L; Hiort O; Werner R; Kulle AE; Ammerpohl O; Holterhus PM
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4630-4638. PubMed ID: 31180485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Repression of Androgen Receptor Transcription in Mutation-Negative Androgen Insensitivity Syndrome (AIS Type II).
    Hornig NC; Rodens P; Dörr H; Hubner NC; Kulle AE; Schweikert HU; Welzel M; Bens S; Hiort O; Werner R; Gonzalves S; Eckstein AK; Cools M; Verrijn-Stuart A; Stunnenberg HG; Siebert R; Ammerpohl O; Holterhus PM
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4617-4627. PubMed ID: 30124873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity.
    Hornig NC; Ukat M; Schweikert HU; Hiort O; Werner R; Drop SL; Cools M; Hughes IA; Audi L; Ahmed SF; Demiri J; Rodens P; Worch L; Wehner G; Kulle AE; Dunstheimer D; Müller-Roßberg E; Reinehr T; Hadidi AT; Eckstein AK; van der Horst C; Seif C; Siebert R; Ammerpohl O; Holterhus PM
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4468-4477. PubMed ID: 27583472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression and normal nucleotide sequence of androgen receptor gene coding and promoter regions in a family with partial androgen insensitivity syndrome.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Hurley DM
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):281-8. PubMed ID: 9156036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and genetic heterogeneity of mixed gonadal dysgenesis: does "disorders of sexual development (DSD)" classification based on new Chicago consensus cover all sex chromosome DSD?
    Ocal G; Berberoğlu M; Sıklar Z; Ruhi HI; Tükün A; Camtosun E; Savaş Erdeve S; Hacıhamdioğlu B; Fitöz S
    Eur J Pediatr; 2012 Oct; 171(10):1497-502. PubMed ID: 22644991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome.
    Appari M; Werner R; Wünsch L; Cario G; Demeter J; Hiort O; Riepe F; Brooks JD; Holterhus PM
    J Mol Med (Berl); 2009 Jun; 87(6):623-32. PubMed ID: 19330472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling.
    Köhler B; Lumbroso S; Leger J; Audran F; Grau ES; Kurtz F; Pinto G; Salerno M; Semitcheva T; Czernichow P; Sultan C
    J Clin Endocrinol Metab; 2005 Jan; 90(1):106-11. PubMed ID: 15522944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered transcription profiles of key-enzymes of androgen biosynthesis in genital skin fibroblasts from patients with 46,XY disorders of sex development (DSD).
    Hoppe U; Wünsch L; Holterhus PM; Jocham D; Richter-Unruh A; Hiort O
    Sex Dev; 2007; 1(4):230-7. PubMed ID: 18391534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 45,X/46,XY mosaicism: phenotypic characteristics, growth, and reproductive function--a retrospective longitudinal study.
    Lindhardt Johansen M; Hagen CP; Rajpert-De Meyts E; Kjærgaard S; Petersen BL; Skakkebæk NE; Main KM; Juul A
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1540-9. PubMed ID: 22605431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor.
    Holterhus PM; Hiort O; Demeter J; Brown PO; Brooks JD
    Genome Biol; 2003; 4(6):R37. PubMed ID: 12801411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene.
    Weidemann W; Linck B; Haupt H; Mentrup B; Romalo G; Stockklauser K; Brinkmann AO; Schweikert HU; Spindler KD
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):733-9. PubMed ID: 9039340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrotestosterone induces minor transcriptional alterations in genital skin fibroblasts of children with and without androgen insensitivity.
    Tanase-Nakao K; Mizuno K; Hayashi Y; Kojima Y; Hara M; Matsumoto K; Matsubara Y; Igarashi M; Miyado M; Fukami M
    Endocr J; 2019 Apr; 66(4):387-393. PubMed ID: 30787207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic spectrum of 45,X/46,XY individuals.
    Rosenberg C; Frota-Pessoa O; Vianna-Morgante AM; Chu TH
    Am J Med Genet; 1987 Jul; 27(3):553-9. PubMed ID: 3631129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mosaicism due to a somatic mutation of the androgen receptor gene determines phenotype in androgen insensitivity syndrome.
    Holterhus PM; Brüggenwirth HT; Hiort O; Kleinkauf-Houcken A; Kruse K; Sinnecker GH; Brinkmann AO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3584-9. PubMed ID: 9360511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
    Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations.
    Holterhus PM; Werner R; Hoppe U; Bassler J; Korsch E; Ranke MB; Dörr HG; Hiort O
    J Mol Med (Berl); 2005 Dec; 83(12):1005-13. PubMed ID: 16283146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete testicular feminization syndrome: studies on androgen receptor(AR) function, AR gene analysis, and aromatase activities at puberty and long-term observations of clinical and hormonal features from infancy to puberty.
    Isurugi K; Hasegawa F; Shibahara N; Mori H; Shima H; Harada N; Hasegawa T; Honma S; Imasaki K; Nawata H
    Endocr J; 1996 Oct; 43(5):557-64. PubMed ID: 8980896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of two functionally different androgen receptors in a patient with androgen insensitivity.
    Holterhus PM; Sinnecker GH; Wollmann HA; Struve D; Homburg N; Kruse K; Hiort O
    Eur J Pediatr; 1999 Sep; 158(9):702-6. PubMed ID: 10485299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The diagnosis, treatment and following up of 7 patients with 45, X/46, XY mixed gonadal dysgenesis].
    Chen G; Dou J; Yang G; Gu W; Du J; Chen K; Zang L; Jin N; Wang X; Yang L; Lyu Z; Ba J; Lu J; Li J; Pan C; Mu Y
    Zhonghua Nei Ke Za Zhi; 2015 Nov; 54(11):954-8. PubMed ID: 26759215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth data and tumour risk of 32 Chinese children and adolescents with 45,X/46,XY mosaicism.
    Pan L; Su Z; Song J; Xu W; Liu X; Zhang L; Li S;
    BMC Pediatr; 2019 May; 19(1):143. PubMed ID: 31060547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.